drugset / Trial / NCT05773950
Triple Therapy of Dexamethasone, Palonosetron, and Fosaprepitant As PONV Prevention
RandomizedParallel-groupQuadruple-blindPrevention
Summary
As a preventive for postoperative nausea and vomiting in patients undergoing laparoscopic gynecological surgery, the investigators shall investigate the efficacy of the triple therapy of dexamethasone, palonosetron, and fosaprepitant comparing to dual therapy of dexamethasone and palonosetron.
Timeline
- Start
- 2023-08-18
- Primary completion
- 2025-12
- Completion
- 2025-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fosaprepitant | Other / unclassified | 150 mg | — |
Indications
No indication recorded.